This study analyzed the Fitterfly Diabetes CGM digital therapeutics program for improving glycemic control and metabolic parameters among 145 people with T2DM BMI ≥25.0 kg/m2. In week-2, a median reduction in average blood glucose and TAR was observed by -8.00 mg/dl and -5.40 % from week-1. TIR increased by 6.00 %. After the program, median reduction in HbA1c, weight and BMI was observed by -1.00 %, -2.30 kg, and -0.80 kg/m2. The Fitterfly Diabetes CGM program can help in improved diabetes management, as significant improvement in glycemic control and metabolic parameters was observed.